Literature DB >> 17366221

Is risky pediatric research without prospect of direct benefit ever justified?

Rebecca A Martin1, Jason Scott Robert.   

Abstract

Mesh：

Year:  2007        PMID： 17366221     DOI： 10.1080/15265160601171606

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  3 in total

1.  Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

2.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

3.  Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosa.

Authors:  Christine Prodinger; Anja Diem; Katherina Ude-Schoder; Josefina Piñón-Hofbauer; Sophie Kitzmueller; Johann W Bauer; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-07-10       Impact factor: 4.123
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.